File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.vaccine.2013.02.041
- Scopus: eid_2-s2.0-84886784476
- PMID: 23499603
- WOS: WOS:000327419800016
Supplementary
- Citations:
- Appears in Collections:
Article: Template Protocol For Clinical Trials Investigating Vaccines—focus On Safety Elements
Title | Template Protocol For Clinical Trials Investigating Vaccines—focus On Safety Elements |
---|---|
Authors | |
Keywords | Clinical trial Immunization Protocol Safety Vaccine |
Issue Date | 2013 |
Citation | Vaccine, 2013, v. 31, p. 5602-620 How to Cite? |
Abstract | This document is intended as a guide to the protocol development for trials of prophylactic vaccines. Thetemplate may serve phases I–IV clinical trials protocol development to include safety relevant informationas required by the regulatory authorities and as deemed useful by the investigators. This document mayalso be helpful for future site strengthening efforts. |
Persistent Identifier | http://hdl.handle.net/10722/198059 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bonhoeffer, J | en_US |
dc.contributor.author | Imoukhuede, EB | en_US |
dc.contributor.author | Aldrovandi, G | en_US |
dc.contributor.author | Bachtiar, NS | en_US |
dc.contributor.author | Chan, ES | en_US |
dc.contributor.author | Chang, S | en_US |
dc.contributor.author | Chen, RT | en_US |
dc.contributor.author | Fernandopulle, R | en_US |
dc.contributor.author | Goldenthal, KL | en_US |
dc.contributor.author | Heffelfinger, JD | en_US |
dc.contributor.author | Hossain, S | en_US |
dc.contributor.author | Jevaji, I | en_US |
dc.contributor.author | Khamesipour, A | en_US |
dc.contributor.author | Kochhar, S | en_US |
dc.contributor.author | Makhene, M | en_US |
dc.contributor.author | Malkin, E | en_US |
dc.contributor.author | Nalin, D | en_US |
dc.contributor.author | Prevots, R | en_US |
dc.contributor.author | Ramasamy, R | en_US |
dc.contributor.author | Sellers, S | en_US |
dc.contributor.author | Vekemans, J | en_US |
dc.contributor.author | Walker, KB | en_US |
dc.contributor.author | Wilson, P | en_US |
dc.contributor.author | Wong, VCN | en_US |
dc.contributor.author | Zaman, K | en_US |
dc.contributor.author | Heininger, U | en_US |
dc.date.accessioned | 2014-06-25T02:43:48Z | - |
dc.date.available | 2014-06-25T02:43:48Z | - |
dc.date.issued | 2013 | en_US |
dc.identifier.citation | Vaccine, 2013, v. 31, p. 5602-620 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/198059 | - |
dc.description.abstract | This document is intended as a guide to the protocol development for trials of prophylactic vaccines. Thetemplate may serve phases I–IV clinical trials protocol development to include safety relevant informationas required by the regulatory authorities and as deemed useful by the investigators. This document mayalso be helpful for future site strengthening efforts. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Vaccine | en_US |
dc.subject | Clinical trial | - |
dc.subject | Immunization | - |
dc.subject | Protocol | - |
dc.subject | Safety | - |
dc.subject | Vaccine | - |
dc.title | Template Protocol For Clinical Trials Investigating Vaccines—focus On Safety Elements | en_US |
dc.type | Article | en_US |
dc.identifier.email | Wong, VCN: vcnwong@hku.hk | en_US |
dc.identifier.authority | Wong, VCN=rp00334 | en_US |
dc.identifier.doi | 10.1016/j.vaccine.2013.02.041 | en_US |
dc.identifier.pmid | 23499603 | - |
dc.identifier.scopus | eid_2-s2.0-84886784476 | - |
dc.identifier.hkuros | 229131 | en_US |
dc.identifier.volume | 31 | en_US |
dc.identifier.spage | 5602 | en_US |
dc.identifier.epage | 620 | en_US |
dc.identifier.isi | WOS:000327419800016 | - |